전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved667 programs
CGTLimited DatastaleThe Catholic University of KoreaPhase 2

Ex vivo-expanded NK cell enriched lymphocytes (ANKL, ANKL(Ex vivo-expanded NK cell enriched lymphocytes))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 4Status Active
CGTLimited DatastaleBeijing BiotechPhase 2

DLL3-CAR-NK cells (DLL3-CAR-NK cells)

Extensive Stage Lung Small Cell Cancer · SCLC, Extensive Stage

#SCLCExtensiveStage#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 4Status Recruiting
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

Icrucumab (Icrucumab)

Colon Cancer; Rectal Cancer · Carcinoma of Urinary Tract

#CarcinomaofUrinaryTract#Antibody#Phase2#monoclonal-antibody#ColonCancer+2
Trials 4Status Active
ADCLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Patritumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#BreastNeoplasms+2
Trials 4Status Recruiting
AntibodyLimited DatastaleMerckPhase 2

pembrolizumab (Keytruda, SD-101 + Pembrolizumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 4Status Recruiting
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 2

TGFBR2 KO CAR27/IL-15 NK cells (TGFBR2 KO CAR27/IL-15 NK cells)

Gastric Cancer, Metastatic · Lymphoid

#Lymphoid#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 4Status Recruiting
AntibodyLimited DatastaleRegeneronPhase 2

VV1 + Cemiplimab (VV1 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 4Status Recruiting
AntibodyLimited DatastalePeregrine PharmaceuticalsPhase 2

bavituximab (bavituximab)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Peregrine
Trials 4Status Active
CGTLimited DatastaleTmunity Therapeutics, a wholly …Phase 1

huCART-meso cells (huCART-meso cells)

Pancreatic Cancer; Cancer of the Pancreas · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 4Status Discontinued
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab)

Liver Cancer; Antibody · Lung Cancer

#LungCancer#Antibody#Phase2#monoclonal-antibody#LiverCancer+1
Trials 4Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab)

Hepatic Cancer; Surgery · Lung Cancer

#LungCancer#Antibody#Phase2#monoclonal-antibody#HepaticCancer+2
Trials 4Status Recruiting
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin+Anlotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#antibody-drug-conjugate#RemeGen
Trials 3Status Active
CGTStandard DatabasestaleImmunityBio, Inc.Phase 2

PSA-based Oncolytic Virus (ETBX-071, ETBX-071 (PSA-based Oncolytic Virus))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 3Status Discontinued
CGTLimited DatastalePeter MacCallum Cancer Centre, …Phase 1

LeY CAR T cells (LeY CAR T cells)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 3Status Active
AntibodyCurated CorestaleSutro Biopharma, Inc.Phase 3

Luveltamab tazevibulin (Luveltamab tazevibulin)

Ovarian Cancer; Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+2
Trials 3Status Discontinued
ADCLimited DatastaleHenry Ford Health SystemPhase 1

sacituzumab govitecan (Trodelvy, Sacituzumab govetican)

Gastrointestinal Cancer · Gastrointestinal Cancer

#GastrointestinalCancer#ADC#Phase1#antibody-drug-conjugate#Henry
Trials 3Status Recruiting
CGTLimited DatastaleCancer Institute and Hospital, …Phase 1

anti-PSMA CAR-NK (anti-PSMA CAR-NK)

Prostate Cancer Castration-resistant Prostate Cancer · PSMA

#PSMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Phase 1

anti-meso-CAR vector transduced T cells (anti-meso-CAR vector transduced T cells)

Malignant Mesothelioma; Pancreatic Cancer · Malignant Mesothelioma

#MalignantMesothelioma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, disitamab vedotin, sintilimab, capecitabine)

Rectal Cancer · Rectal Cancer

#RectalCancer#ADC#Phase2#antibody-drug-conjugate#RemeGen
Trials 3Status Recruiting
AntibodyLimited DatastaleMacroGenicsPhase 3

margetuximab (margetuximab)

Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#monoclonal-antibody#StageIIBreastCancer+1
Trials 3Status Active

9 / 34 pages

← PreviousNext →